- Home
- QURE
QURE
uniQure N.V.
as 11-21-2024 11:38am EST
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
| Founded: | 1998 | Country: | Netherlands |
| Employees: | N/A | City: | AMSTERDAM |
| Market Cap: | 432.6M | IPO Year: | 2007 |
| Target Price: | $17.00 | AVG Volume (30 days): | 782.4K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.73 - $11.35 | Next Earning Date: | 11-05-2024 |
| Revenue: | $28,587,000 | Revenue Growth: | -74.45% |
| Revenue Growth (this year): | 157.96% | Revenue Growth (next year): | -5.83% |
Latest uniQure N.V. News
QURE Breaking Stock News: Dive into QURE Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 hours ago
uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy
Zacks
13 days ago
Wall Street Analysts Believe uniQure (QURE) Could Rally 169.18%: Here's is How to Trade
Simply Wall St.
14 days ago
What Does The Future Hold For uniQure N.V. (NASDAQ:QURE)? These Analysts Have Been Cutting Their Estimates
Simply Wall St.
15 days ago
uniQure Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Zacks
16 days ago
UniQure (QURE) Reports Q3 Loss, Lags Revenue Estimates
Associated Press Finance
16 days ago
UniQure: Q3 Earnings Snapshot
GlobeNewswire
16 days ago
uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
Zacks
22 days ago
Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth
Compare QURE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QURE uniQure N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.